NCT04532489View on ClinicalTrials.gov

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
RadiotracerHypertensionCholesterol
Interventions
DRUG

FNP-59

FNP-59, a radiotracer, is administered for PET/CT scans.

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
lead

Benjamin Viglianti

OTHER